Jacobs Levy Equity Management
BEAT

Jacobs Levy Equity Management’s BioTelemetry, Inc. BEAT Stock Holding History

Jacobs Levy Equity Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-42,106
Closed -$417K – 1132
2013
Q3 		$417K Sell
42,106
-43,400
-51% -$342K 0.01% 733
2013
Q2 		$504K Buy
+85,506
New +$288K 0.01% 732

Other funds holding BEAT

CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jacobs Levy Equity Management's BEAT Position: Q4 2013 in Review

Jacobs Levy Equity Management sold out of BioTelemetry, Inc. (BEAT) in Q4 2013, closing a stake of 42,106 shares — an estimated $417K sold.

Jacobs Levy Equity Management first reported a position in BEAT in Q2 2013 and held it in 2 quarters. The position peaked at $504K in Q2 2013. 77 funds tracked by Wall St. Rank hold BEAT as of Q4 2013.

  • Jacobs Levy Equity Management reported no remaining BioTelemetry, Inc. position as of Q4 2013 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 42,106 BioTelemetry, Inc. shares in Q4 2013, an estimated $417K.
  • Jacobs Levy Equity Management first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 2 quarters.
  • Jacobs Levy Equity Management's BioTelemetry, Inc. position peaked at $504K in Q2 2013.
  • 77 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2013.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2013, filed 14 Feb 2014.